Zacks Investment Research
29 Jun 2026, 08:21 UTC · 2h ago
EverCommerce (EVCM) Surges 6.5%: Is This an Indication of Further Gains?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
29 Jun 2026, 08:21 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
EverCommerce (EVCM) shares rose 6.5% to $9.31 on high trading volume. — Direct positive price action on high volume indicates short-term bullish momentum.
+0.30AudioEye (AEYE) shares closed the last trading session 6.5% lower at $5.59. — Direct negative price action and a month-long decline signal bearish sentiment for the name.
-0.30EverCommerce is expanding its AI-powered workflow solutions, including ZyraTalk AI and EverHealth AI Scribe, to drive revenue and retention. — Adoption of AI products is a positive fundamental driver for software companies' long-term growth.
+0.20EverCommerce is expected to report quarterly earnings of $0.04 per share, a 33.3% increase year-over-year. — Strong expected earnings growth typically supports a higher valuation.
Continue reading
6 related stories
Top 3 movers · tap to explore
Which stocks this story touches
Shares closed the last trading session 6.5% lower and have returned -22.1% over the past month.
Shares ended the last trading session 6.5% higher due to growing adoption of AI-powered workflow solutions.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
1h ago
